Bessemer Group
CBPO

Bessemer Group’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Bessemer Group’s Portfolio CBPO Stock Details CBPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-71
Closed -$9K – 2145
2016
Q3 		$9K Buy
+71
New +$8.38K ﹤0.01% 1550
2016
Q2 		– Sell
-525
Closed -$60K – 1554
2016
Q1 		$60K Buy
+525
New +$61.6K ﹤0.01% 879

Other funds holding CBPO

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Bessemer Group's CBPO Position: Q4 2016 in Review

Bessemer Group sold out of China Biologic Products Holdings, Inc. (CBPO) in Q4 2016, closing a stake of 71 shares — an estimated $9K sold.

Bessemer Group first reported a position in CBPO in Q1 2016 and held it in 2 quarters. The position peaked at $60K in Q1 2016. 143 funds tracked by Wall St. Rank hold CBPO as of Q4 2016.

  • Bessemer Group reported no remaining China Biologic Products Holdings, Inc. position as of Q4 2016 after selling out during the quarter.
  • Bessemer Group sold 71 China Biologic Products Holdings, Inc. shares in Q4 2016, an estimated $9K.
  • Bessemer Group first reported a position in China Biologic Products Holdings, Inc. in Q1 2016 and held it in 2 quarters.
  • Bessemer Group's China Biologic Products Holdings, Inc. position peaked at $60K in Q1 2016.
  • 143 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q4 2016.

Based on Bessemer Group's 13F filing for Q4 2016, filed 7 Feb 2017.